by Truveta staff | Jun 17, 2024 | Data, News, Technology
Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s...
by Truveta staff | May 14, 2024 | News
Truveta Research and collaborators Anupam B. Jena, MD, PhD and Christopher Worsham, MD, MPH received the ISPOR 2024 Best General Poster Research Presentation Award for their poster presentation, HSD72: Baseline A1C and BMI Trends for People with Type 2 Diabetes...
by Truveta staff | May 13, 2024 | News
Today Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair. Truveta’s Board of Directors ensures Truveta is operating in pursuit of its mission, providing strategic, scientific, and operational direction. With...
by Truveta staff | May 1, 2024 | Data, News, Technology
Today we are excited to announce the availability of expanded concepts from clinical notes — including family history, medication details reported to providers, and complex concepts for a wide range of therapeutic areas from cardiology to rare disease and more –...
by Truveta staff | May 1, 2024 | News
Truveta Data delivers complete EHR data, including clinician notes and images, from more than 30 health systems, linked with SDOH, mortality and claims data, for scientifically rigorous research. Truveta Data provides regulatory grade, daily updated data from more...
by Truveta staff | Apr 25, 2024 | News, Technology
Truveta was named winner of a Gold Stevie® Award for Achievement in Science or Technology, as well as a Silver for Most Innovative Company of the Year in the 22nd Annual American Business Awards® today. The American Business Awards are the U.S.A.’s premier business...
